ALDH-2 inhibitors in the treatment of addiction

Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZABLOCKI JEFF, KALLA RAO, ABELMAN MATTHEW, PERRY THAO, YAO LINA, TAO GUOXIN, ELZEIN ELFATIH, KOBAYASHI TETSUYA, ORGAN MICHAEL, LI XIAOFEN, FAN PEIDONG, DIAMOND IVAN, JIANG ZHAN, AROLFO MARIA PIA, KEUNG WING MING, JIANG ROBERT, BILOKIN YAROSLAV
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZABLOCKI JEFF
KALLA RAO
ABELMAN MATTHEW
PERRY THAO
YAO LINA
TAO GUOXIN
ELZEIN ELFATIH
KOBAYASHI TETSUYA
ORGAN MICHAEL
LI XIAOFEN
FAN PEIDONG
DIAMOND IVAN
JIANG ZHAN
AROLFO MARIA PIA
KEUNG WING MING
JIANG ROBERT
BILOKIN YAROSLAV
description Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8158810B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8158810B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8158810B23</originalsourceid><addsrcrecordid>eNrjZNB39HHx0DVSyMzLyEzKLMkvKgYyFUoyUhVKilITS3JT80oU8tMUElNSMpNLMvPzeBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJfGiwhaGphYWhgZORMRFKAGb3Kck</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ALDH-2 inhibitors in the treatment of addiction</title><source>esp@cenet</source><creator>ZABLOCKI JEFF ; KALLA RAO ; ABELMAN MATTHEW ; PERRY THAO ; YAO LINA ; TAO GUOXIN ; ELZEIN ELFATIH ; KOBAYASHI TETSUYA ; ORGAN MICHAEL ; LI XIAOFEN ; FAN PEIDONG ; DIAMOND IVAN ; JIANG ZHAN ; AROLFO MARIA PIA ; KEUNG WING MING ; JIANG ROBERT ; BILOKIN YAROSLAV</creator><creatorcontrib>ZABLOCKI JEFF ; KALLA RAO ; ABELMAN MATTHEW ; PERRY THAO ; YAO LINA ; TAO GUOXIN ; ELZEIN ELFATIH ; KOBAYASHI TETSUYA ; ORGAN MICHAEL ; LI XIAOFEN ; FAN PEIDONG ; DIAMOND IVAN ; JIANG ZHAN ; AROLFO MARIA PIA ; KEUNG WING MING ; JIANG ROBERT ; BILOKIN YAROSLAV</creatorcontrib><description>Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.</description><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120417&amp;DB=EPODOC&amp;CC=US&amp;NR=8158810B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120417&amp;DB=EPODOC&amp;CC=US&amp;NR=8158810B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZABLOCKI JEFF</creatorcontrib><creatorcontrib>KALLA RAO</creatorcontrib><creatorcontrib>ABELMAN MATTHEW</creatorcontrib><creatorcontrib>PERRY THAO</creatorcontrib><creatorcontrib>YAO LINA</creatorcontrib><creatorcontrib>TAO GUOXIN</creatorcontrib><creatorcontrib>ELZEIN ELFATIH</creatorcontrib><creatorcontrib>KOBAYASHI TETSUYA</creatorcontrib><creatorcontrib>ORGAN MICHAEL</creatorcontrib><creatorcontrib>LI XIAOFEN</creatorcontrib><creatorcontrib>FAN PEIDONG</creatorcontrib><creatorcontrib>DIAMOND IVAN</creatorcontrib><creatorcontrib>JIANG ZHAN</creatorcontrib><creatorcontrib>AROLFO MARIA PIA</creatorcontrib><creatorcontrib>KEUNG WING MING</creatorcontrib><creatorcontrib>JIANG ROBERT</creatorcontrib><creatorcontrib>BILOKIN YAROSLAV</creatorcontrib><title>ALDH-2 inhibitors in the treatment of addiction</title><description>Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB39HHx0DVSyMzLyEzKLMkvKgYyFUoyUhVKilITS3JT80oU8tMUElNSMpNLMvPzeBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJfGiwhaGphYWhgZORMRFKAGb3Kck</recordid><startdate>20120417</startdate><enddate>20120417</enddate><creator>ZABLOCKI JEFF</creator><creator>KALLA RAO</creator><creator>ABELMAN MATTHEW</creator><creator>PERRY THAO</creator><creator>YAO LINA</creator><creator>TAO GUOXIN</creator><creator>ELZEIN ELFATIH</creator><creator>KOBAYASHI TETSUYA</creator><creator>ORGAN MICHAEL</creator><creator>LI XIAOFEN</creator><creator>FAN PEIDONG</creator><creator>DIAMOND IVAN</creator><creator>JIANG ZHAN</creator><creator>AROLFO MARIA PIA</creator><creator>KEUNG WING MING</creator><creator>JIANG ROBERT</creator><creator>BILOKIN YAROSLAV</creator><scope>EVB</scope></search><sort><creationdate>20120417</creationdate><title>ALDH-2 inhibitors in the treatment of addiction</title><author>ZABLOCKI JEFF ; KALLA RAO ; ABELMAN MATTHEW ; PERRY THAO ; YAO LINA ; TAO GUOXIN ; ELZEIN ELFATIH ; KOBAYASHI TETSUYA ; ORGAN MICHAEL ; LI XIAOFEN ; FAN PEIDONG ; DIAMOND IVAN ; JIANG ZHAN ; AROLFO MARIA PIA ; KEUNG WING MING ; JIANG ROBERT ; BILOKIN YAROSLAV</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8158810B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ZABLOCKI JEFF</creatorcontrib><creatorcontrib>KALLA RAO</creatorcontrib><creatorcontrib>ABELMAN MATTHEW</creatorcontrib><creatorcontrib>PERRY THAO</creatorcontrib><creatorcontrib>YAO LINA</creatorcontrib><creatorcontrib>TAO GUOXIN</creatorcontrib><creatorcontrib>ELZEIN ELFATIH</creatorcontrib><creatorcontrib>KOBAYASHI TETSUYA</creatorcontrib><creatorcontrib>ORGAN MICHAEL</creatorcontrib><creatorcontrib>LI XIAOFEN</creatorcontrib><creatorcontrib>FAN PEIDONG</creatorcontrib><creatorcontrib>DIAMOND IVAN</creatorcontrib><creatorcontrib>JIANG ZHAN</creatorcontrib><creatorcontrib>AROLFO MARIA PIA</creatorcontrib><creatorcontrib>KEUNG WING MING</creatorcontrib><creatorcontrib>JIANG ROBERT</creatorcontrib><creatorcontrib>BILOKIN YAROSLAV</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZABLOCKI JEFF</au><au>KALLA RAO</au><au>ABELMAN MATTHEW</au><au>PERRY THAO</au><au>YAO LINA</au><au>TAO GUOXIN</au><au>ELZEIN ELFATIH</au><au>KOBAYASHI TETSUYA</au><au>ORGAN MICHAEL</au><au>LI XIAOFEN</au><au>FAN PEIDONG</au><au>DIAMOND IVAN</au><au>JIANG ZHAN</au><au>AROLFO MARIA PIA</au><au>KEUNG WING MING</au><au>JIANG ROBERT</au><au>BILOKIN YAROSLAV</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ALDH-2 inhibitors in the treatment of addiction</title><date>2012-04-17</date><risdate>2012</risdate><abstract>Disclosed are novel isoflavone derivatives having the structure of Formula I which are useful as ALDH-2 inhibitors for treating mammals for dependence upon drugs of addiction, for example addiction to dopamine-producing agent such as cocaine, morphine, amphetamines, nicotine, and alcohol.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US8158810B2
source esp@cenet
subjects ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title ALDH-2 inhibitors in the treatment of addiction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T11%3A10%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZABLOCKI%20JEFF&rft.date=2012-04-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8158810B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true